Alvotech - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALVO Nasdaq 2834 www.alvotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alvotech

Alvotech to Present at Upcoming Investor Conferences in November - Nov 2nd, 2026 5:00 am
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026 - Oct 28th, 2026 5:00 am
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates - Oct 27th, 2026 5:15 am
New Strong Sell Stocks for October 21st - Oct 21st, 2026 3:43 am
New Strong Sell Stocks for October 20th - Oct 21st, 2026 2:39 am
Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says - Oct 20th, 2026 10:11 am
Alvotech shares jump premarket after FDA approves new Simlandi process - Oct 20th, 2026 3:22 am
Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch - Oct 20th, 2026 2:30 am
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch - Oct 20th, 2026 2:30 am
Alvotech Stock In Focus After Europe Filing For Eylea 8 Mg Copycat - Oct 16th, 2026 5:19 pm
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg - Oct 14th, 2026 2:30 am
LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply - Oct 8th, 2026 5:17 am
Alvotech (ALVO) Could Be 14% Undervalued On Manufacturing Capacity Updates - Oct 8th, 2026 5:15 am
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply - Oct 6th, 2026 2:37 pm
Alvotech Soars 13% on FDA Nod That “Effectively Doubles” US Humira Biosimilar Capacity - Oct 5th, 2026 1:14 pm
Alvotech stock surges after FDA manufacturing approval - Oct 5th, 2026 9:21 am